The latest Neogenomics Inc. (NEO) Stock Technical Bulletin
BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]
There Is Nothing Like Neogenomics Inc. (NEO) Stock
BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]
Earnings and valuation of Neogenomics Inc. (NEO) Stock are impressive
BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]
Neogenomics Inc. (NEO) Stock at a key inflection point
BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]
Neogenomics Inc. (NASDAQ:NEO) Stock is trading at a margin of -2.50% From 20-Day SMA
BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]
Why Neogenomics Inc. (NASDAQ:NEO) Stock declined -27.18% in Last Three Months?
BTIG Research lowered the price target for the Neogenomics Inc. (NASDAQ:NEO) stock to “a Buy”. The rating was released on December 29, 2023, according to finviz. The stock was upgraded by BTIG Research, who disclosed in a research note on May 09, 2023, from Neutral to Buy and set the price objective to $25. In […]
